[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100521303":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":23,"locations":31,"responsibleParty":232,"collaborators":11,"id":234,"slug":235,"hasResults":236,"nctId":237,"briefTitle":238,"officialTitle":239,"acronym":11,"eligibilityCriteria":240,"healthyVolunteers":236,"sex":241,"minAge":242,"maxAge":11,"enrollmentInfo":243,"targetDuration":11,"studyType":246,"phases":247,"briefSummary":249,"conditions":250,"keywords":252,"overallStatus":34,"whyStopped":11,"lastUpdateSubmitDate":258,"lastUpdatePostDateStruct":259,"startDateStruct":262,"completionDateStruct":264,"leadSponsor":266,"locationsCount":267},{"fullName":5,"class":6},"Bristol-Myers Squibb","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Administration of BMS-986460","EXPERIMENTAL",null,[13],"Drug: BMS-986460",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":11},"DRUG","BMS-986460","Specified dose on specified days.",[9],[21],{"name":5,"affiliation":5,"role":22},"STUDY_DIRECTOR",[24,29],{"name":25,"role":26,"phone":27,"phoneExt":11,"email":28},"BMS Clinical Trials Contact Center www.BMSClinicalTrials.com","CONTACT","855-907-3286","Clinical.Trials@bms.com",{"name":30,"role":26,"phone":11,"phoneExt":11,"email":11},"First line of the email MUST contain NCT # and Site #.",[32,50,64,78,91,105,116,125,139,155,168,183,192,206,220],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Stanford Cancer Center","RECRUITING","Palo Alto","California","94304","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-122.14302,37.44188,{"lat":44,"lon":43},[47],{"name":48,"role":26,"phone":49,"phoneExt":11,"email":11},"Sandhya Srinivas, Site 0004","650-725-2078",{"facility":51,"status":34,"city":52,"state":53,"zip":54,"country":38,"countryCode":39,"cosmosGeoPoint":55,"geoPoint":59,"contacts":60},"Florida Cancer Specialists Sarasota Drug Development Unit","Sarasota","Florida","34232",{"type":41,"coordinates":56},[57,58],-82.53065,27.33643,{"lat":58,"lon":57},[61],{"name":62,"role":26,"phone":63,"phoneExt":11,"email":11},"Manish Patel, Site 0007","941-377-9993",{"facility":65,"status":34,"city":66,"state":67,"zip":68,"country":38,"countryCode":39,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Dana-Farber Cancer Institute","Boston","Massachusetts","02215",{"type":41,"coordinates":70},[71,72],-71.05977,42.35843,{"lat":72,"lon":71},[75],{"name":76,"role":26,"phone":77,"phoneExt":11,"email":11},"Atish Choudhury, Site 0003","000-000-0000",{"facility":79,"status":34,"city":80,"state":80,"zip":81,"country":38,"countryCode":39,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Memorial Sloan Kettering Cancer Center","New York","10065",{"type":41,"coordinates":83},[84,85],-74.00597,40.71427,{"lat":85,"lon":84},[88],{"name":89,"role":26,"phone":90,"phoneExt":11,"email":11},"Dana Rathkopf, Site 0002","646-422-4379",{"facility":92,"status":34,"city":93,"state":94,"zip":95,"country":38,"countryCode":39,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Duke Cancer Institute","Durham","North Carolina","27710",{"type":41,"coordinates":97},[98,99],-78.89862,35.99403,{"lat":99,"lon":98},[102],{"name":103,"role":26,"phone":104,"phoneExt":11,"email":11},"Andrew Armstrong, Site 0001","919-668-8797",{"facility":106,"status":107,"city":108,"state":109,"zip":110,"country":38,"countryCode":39,"cosmosGeoPoint":111,"geoPoint":115,"contacts":11},"Local Institution - 0006","WITHDRAWN","San Antonio","Texas","78229",{"type":41,"coordinates":112},[113,114],-98.49363,29.42412,{"lat":114,"lon":113},{"facility":117,"status":34,"city":108,"state":109,"zip":110,"country":38,"countryCode":39,"cosmosGeoPoint":118,"geoPoint":120,"contacts":121},"NEXT Oncology",{"type":41,"coordinates":119},[113,114],{"lat":114,"lon":113},[122],{"name":123,"role":26,"phone":124,"phoneExt":11,"email":11},"David Sommerhalder, Site 0008","210-580-9500",{"facility":126,"status":34,"city":127,"state":128,"zip":129,"country":38,"countryCode":39,"cosmosGeoPoint":130,"geoPoint":134,"contacts":135},"Fred Hutchinson Cancer Center","Seattle","Washington","98109",{"type":41,"coordinates":131},[132,133],-122.33207,47.60621,{"lat":133,"lon":132},[136],{"name":137,"role":26,"phone":138,"phoneExt":11,"email":11},"Ruben Raychaudhuri, Site 0005","206-618-8002",{"facility":140,"status":141,"city":142,"state":143,"zip":144,"country":145,"countryCode":146,"cosmosGeoPoint":147,"geoPoint":151,"contacts":152},"Local Institution - 0009","NOT_YET_RECRUITING","Toronto","Ontario","M5G 2M9","Canada","CA",{"type":41,"coordinates":148},[149,150],-79.39864,43.70643,{"lat":150,"lon":149},[153],{"name":154,"role":26,"phone":11,"phoneExt":11,"email":11},"Site 0009",{"facility":156,"status":141,"city":157,"state":158,"zip":159,"country":145,"countryCode":146,"cosmosGeoPoint":160,"geoPoint":164,"contacts":165},"Local Institution - 0011","Montreal","Quebec","H2X 0A9",{"type":41,"coordinates":161},[162,163],-73.58781,45.50884,{"lat":163,"lon":162},[166],{"name":167,"role":26,"phone":11,"phoneExt":11,"email":11},"Site 0011",{"facility":169,"status":141,"city":170,"state":171,"zip":172,"country":173,"countryCode":174,"cosmosGeoPoint":175,"geoPoint":179,"contacts":180},"Local Institution - 0018","Bordeaux","Aquitaine","33076","France","FR",{"type":41,"coordinates":176},[177,178],-0.58046,44.84124,{"lat":178,"lon":177},[181],{"name":182,"role":26,"phone":11,"phoneExt":11,"email":11},"Site 0018",{"facility":184,"status":34,"city":185,"state":186,"zip":187,"country":173,"countryCode":174,"cosmosGeoPoint":11,"geoPoint":11,"contacts":188},"Centre Leon Berard","Lyon Cedex08","Auvergne-Rhône-Alpes","69373",[189],{"name":190,"role":26,"phone":191,"phoneExt":11,"email":11},"Armelle Vinceneux, Site 0013","33426556833",{"facility":193,"status":34,"city":194,"state":195,"zip":196,"country":173,"countryCode":174,"cosmosGeoPoint":197,"geoPoint":201,"contacts":202},"Institut Paoli-Calmettes","Marseille","Nan","13009",{"type":41,"coordinates":198},[199,200],5.38107,43.29695,{"lat":200,"lon":199},[203],{"name":204,"role":26,"phone":205,"phoneExt":11,"email":11},"Gwenaelle Gravis, Site 0019","33491223894",{"facility":207,"status":34,"city":208,"state":209,"zip":210,"country":173,"countryCode":174,"cosmosGeoPoint":211,"geoPoint":215,"contacts":216},"Gustave Roussy","Villejuif","Val-de-Marne","94800",{"type":41,"coordinates":212},[213,214],2.35992,48.7939,{"lat":214,"lon":213},[217],{"name":218,"role":26,"phone":219,"phoneExt":11,"email":11},"Christophe Massard, Site 0014","+33142114211",{"facility":221,"status":141,"city":222,"state":11,"zip":223,"country":173,"countryCode":174,"cosmosGeoPoint":224,"geoPoint":228,"contacts":229},"Local Institution - 0017","Paris","75015",{"type":41,"coordinates":225},[226,227],2.3488,48.85341,{"lat":227,"lon":226},[230],{"name":231,"role":26,"phone":11,"phoneExt":11,"email":11},"Site 0017",{"type":233,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100521303","a-study-to-assess-bms-986460-in-participants-with-metastatic-castration-resistant-prostate-cancer-100521303",false,"NCT06067841","A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer","A Phase 1, Open-label Study of BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer","Inclusion Criteria:\n\n* Participant must have histologically or cytologically confirmed adenocarcinoma of the prostate.\n* Participant must have an Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1.\n* Participant must have prostate specific antigen (PSA) of ≥ 2 ng\u002FmL at Screening\n* Participant must have progressed on androgen deprivation therapy (ADT) and at least one prior secondary hormonal therapy approved for castration-resistant prostate cancer (CRPC)\n\nExclusion Criteria:\n\n* Participant must not have history of brain metastases.\n* Participant must not have impaired cardiac function or clinically significant cardiac disease.\n* Participant must not have any significant medical condition, including active or uncontrolled infection, psychiatric illness, or the presence of laboratory abnormalities, which places the participant at unacceptable risk or prevent participation in the study based on Investigator assessment.\n\nOther protocol-defined inclusion\u002Fexclusion criteria apply","MALE","18 Years",{"count":244,"type":245},140,"ESTIMATED","INTERVENTIONAL",[248],"PHASE1","The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer.",[251],"Metastatic Castration-resistant Prostate Cancer",[253,254,255,256,257],"Prostate Cancer","Castration-resistant prostate cancer","Adenocarcinoma of the prostate","Prostatic Neoplasms Castration-Resistant","Neoplasms","2026-08-07",{"date":260,"type":261},"2026-08-10","ACTUAL",{"date":263,"type":261},"2023-10-18",{"date":265,"type":245},"2031-07-27",{"name":5,"class":6},15]